Susquehanna International Group
AMRX icon

Susquehanna International Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Susquehanna International Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-216,800
Closed -$2.73M – 13103
2025
Q4 		$2.73M Sell
216,800
-85,200
-28% -$975K ﹤0.01% 5048
2025
Q3 		$3.02M Buy
302,000
+210,900
+232% +$1.89M ﹤0.01% 4964
2025
Q2 		$737K Sell
91,100
-66,500
-42% -$501K ﹤0.01% 8218
2025
Q1 		$1.32M Buy
157,600
+46,200
+41% +$386K ﹤0.01% 6546
2024
Q4 		$882K Buy
111,400
+63,800
+134% +$535K ﹤0.01% 7279
2024
Q3 		$396K Sell
47,600
-26,200
-36% -$205K ﹤0.01% 9012
2024
Q2 		$469K Sell
73,800
-55,800
-43% -$354K ﹤0.01% 8421
2024
Q1 		$785K Sell
129,600
-19,600
-13% -$111K ﹤0.01% 7448
2023
Q4 		$906K Buy
149,200
+56,200
+60% +$250K ﹤0.01% 7224
2023
Q3 		$392K Sell
93,000
-600
-0.6% -$2.24K ﹤0.01% 8788
2023
Q2 		$290K Buy
93,600
+73,200
+359% +$156K ﹤0.01% 9513
2023
Q1 		$28.4K Sell
20,400
-5,900
-22% -$11.7K ﹤0.01% 11935
2022
Q4 		$52.3K Sell
26,300
-99,300
-79% -$223K ﹤0.01% 11370
2022
Q3 		$254K Buy
125,600
+40,600
+48% +$114K ﹤0.01% 10232
2022
Q2 		$270K Sell
85,000
-29,300
-26% -$106K ﹤0.01% 9845
2022
Q1 		$477K Sell
114,300
-76,800
-40% -$340K ﹤0.01% 9114
2021
Q4 		$915K Sell
191,100
-139,000
-42% -$693K ﹤0.01% 7542
2021
Q3 		$1.76M Buy
330,100
+78,900
+31% +$397K ﹤0.01% 6114
2021
Q2 		$1.29M Sell
251,200
-31,600
-11% -$180K ﹤0.01% 7053
2021
Q1 		$1.9M Buy
282,800
+16,800
+6% +$93.1K ﹤0.01% 6046
2020
Q4 		$1.22M Sell
266,000
-40,500
-13% -$179K ﹤0.01% 6248
2020
Q3 		$1.19M Sell
306,500
-13,600
-4% -$58.2K ﹤0.01% 5700
2020
Q2 		$1.52M Buy
320,100
+287,300
+876% +$1.18M ﹤0.01% 5002
2020
Q1 		$114K Buy
+32,800
New +$139K ﹤0.01% 9226
2019
Q3 		– Sell
-38,100
Closed -$273K – 10109
2019
Q2 		$273K Buy
38,100
+27,500
+259% +$281K ﹤0.01% 8504
2019
Q1 		$150K Sell
10,600
-26,800
-72% -$354K ﹤0.01% 8049
2018
Q4 		$506K Buy
+37,400
New +$674K ﹤0.01% 6007

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Susquehanna International Group's AMRX Position: Q1 2026 in Review

Susquehanna International Group reduced its Amneal Pharmaceuticals (AMRX) stake by 96% in Q1 2026, selling an estimated $17.1M and leaving 52,543 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #8974.

Susquehanna International Group first reported a position in AMRX in Q2 2018 and has held it in 29 quarters since. The position peaked at $16.7M in Q4 2025. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Susquehanna International Group held 52,543 shares of Amneal Pharmaceuticals worth $653K as of Q1 2026.
  • Susquehanna International Group sold 1,273,997 Amneal Pharmaceuticals shares in Q1 2026, an estimated $17.1M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8974 holding.
  • Susquehanna International Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 29 quarters since.
  • Susquehanna International Group's Amneal Pharmaceuticals position peaked at $16.7M in Q4 2025.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.